Convergence of CRISPR and artificial intelligence: A paradigm shift in biotechnology

CRISPR, or clustered regularly interspaced short palindromic repeats, is a groundbreaking gene-editing technology derived from the bacterial immune system. CRISPR has quickly become a cornerstone in biological research and biotechnology due to its simplicity, efficiency, and versatility. It holds enormous potential for applications ranging from correcting genetic defects and engineering disease-resistant crops to advancing treatments for genetic disorders and cancer. However, the widespread adoption of CRISPR also raises ethical concerns and challenges related to off-target effects, unintended consequences, and equitable access to genetic modification technologies. Artificial Intelligence (AI) has emerged as a transformative force in the field of gene editing, contributing to a revolution in the way genetic modifications are approached and executed. The integration of AI into gene editing processes, such as CRISPR technology, brings forth a multitude of advantages that significantly enhance the precision and efficiency of genetic manipulation. This review article explores how these two powerful technologies are working together. It considers the beneficial relationship between these cutting-edge technologies, demonstrating how AI enhances the accuracy, effectiveness, and adaptability of CRISPR while opening up new possibilities for genome editing, disease detection, drug discovery, and other fields. The article also looks at the problems, ethical concerns, and what might come next as these two technologies team up, giving us a clear picture of how biotechnology is changing in the CRISPR-AI era.